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Viral and microbial infections often elicit programmed cell death as part of the host defense system or as
a component of the survival strategy of the pathogen. It is thus not surprising that pathogens have evolved
an array of toxins and virulence factors to modulate host cell death pathways. Apoptosis, necrosis, and
pyroptosis constitute the three major cell death modes for elimination of infected cells. Herein, we discuss
the signaling pathways underlying the principal host cell death mechanisms and provide an overview of
the strategies employed by viral and microbial pathogens to manipulate these cell death processes.Introduction
The immune system responds to infection in a variety of ways,
ranging from activation of pathways that promote survival to
eliciting programmed cell death. The initial response to infection
is geared toward helping the organism defend against and
recover from infection. This is accomplished through activation
of inflammatory pathways, the recruitment of immune cells to
the site of infection, production of antimicrobial peptides at
mucosal surfaces, and activation of the complement system.
However, if the condition is unresolved, cell death signaling
pathways are activated to eliminate the infected cell from the
organism. This removes the intracellular niche of microbial repli-
cation and exposes intracellular pathogens to extracellular
immune surveillance. In addition, engulfment of dying cells by
macrophages and dendritic cells may promote activation of
the adaptive immune system by presenting viral and microbial
antigens to T cells (Albert, 2004). It is thus not surprising that
microbial pathogens have evolved a variety of strategies to
modulate host cell death and subvert normal host defense
responses (Best, 2008). By inducing host cell death, bacteria
and viruses eliminate key immune cells and evade host defenses
that can compromise their viability. Alternatively, suppression of
host cell death may facilitate replication and proliferation of
viruses and obligate and facultative intracellular microbial path-
ogens. To this end, pathogens are often equipped with virulence
factors that allow dynamic modulation of cell death induction
by a variety of mechanisms, including (1) pore-forming toxins
permitting the extracellular leakage of cellular components, (2)
enzymes and effector proteins delivered into the host cytosol
by specialized secretion systems, and (3) superantigens that
target immune cells.
Apoptosis, necrosis, and pyroptosis constitute the principal
mechanisms by which programmed host cell death occurs
(Figure 1). The term ‘‘programmed cell death’’ refers to geneti-
cally controlled or regulated forms of death, where the cell plays
an active role in its own demise. Each cell death mode is charac-
terized by particular morphological changes and distinctive
molecular signaling pathways. In the following sections, we will
discuss the biochemical basis and the (patho)physiological44 Cell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc.consequences of apoptosis, necrosis, and pyroptosis induction
as well as their modulation in the context of microbial infection.
Apoptosis
Morphology and Signaling Pathways
Apoptosis has emerged as the default programmed cell death
mode for organ shaping during embryonic development and
homeostasis of adult organisms (Strasser et al., 2000). Morpho-
logically, apoptosis is characterized by plasma membrane
blebbing, cell body shrinkage (pyknosis), nuclear condensation
plus fragmentation (karyorrhexis), and formation of membrane-
bound cell fragments (apoptotic bodies) that are rapidly phago-
cytosed in vivo by neighboring cells and resident phagocytes
(Figure 1). As a consequence, apoptosis usually proceeds
without eliciting an inflammatory response because the cyto-
plasmic content is not spilled into the extracellular milieu. In
addition, engulfment of apoptotic cells may actively prevent
the production of inflammatory cytokines by macrophages and
suppress dendritic cell maturation and antigen presentation
(Savill et al., 2002). Biochemical features of apoptosis include
a decrease in mitochondrial inner transmembrane potential,
the activation of selective proteases, the cleavage of chromo-
somal DNA into internucleosomal fragments, the selective
cleavage of various cellular proteins, and the translocation of
phosphatidylserine from the inner to the outer leaflet of the
plasma membrane (Salvesen and Riedl, 2008; Strasser et al.,
2000). These changes are manifestations of an evolutionarily
conserved cell suicide machinery comprising at its core a family
of cysteinyl aspartate-specific proteases (caspases) (Lamkanfi
et al., 2002; Salvesen and Riedl, 2008).
Apoptotic caspases typically signal in a two-step cascade
(Figure 2): ‘‘initiator caspases’’ with large prodomains (i.e., cas-
pases-2, -8, -9, and -10) are first recruited into large protein
complexes where they undergo proximity-induced oligomeriza-
tion and interchain autoprocessing (Boatright et al., 2003; Oberst
et al., 2010). The death-inducing signaling complex (DISC)
and the apoptosome complex are the major scaffolds for prox-
imity-induced autoactivation of initiator caspases. Assembly of
these protein complexes is intrinsically linked to activation of,
Figure 1. Programmed Cell Death Modes and Their Features
The retention of plasmamembrane integrity and the formation of apoptotic bodies render apoptosis an immunologically silent death program. In contrast, inflam-
mation is triggered when cells dying by necrosis or pyroptosis secrete proinflammatory cytokines and release their cytoplasmic content into the extracellular
space. Nuclear condensation and internucleosomal DNA fragmentation are characteristic of apoptosis and pyroptosis, whereas the nuclei of necrotic cells swell
along with other organelles.
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ways. The extrinsic and intrinsic pathways communicate through
activation of the Bcl-2 homology domain 3 (BH3)-only protein Bid
(Saelens et al., 2004).
The extrinsic pathway is triggered by binding of extracellular
death receptor ligands such as tumor necrosis factor (TNF),
Fas ligand (FasL), and TNF-related apoptosis-inducing ligand
(TRAIL) to their respective transmembrane receptors (Peter
and Krammer, 2003; Strasser et al., 2000). Fas, one of the
best-characterized death receptors, plays crucial roles in a
variety of immunological processes. This is reflected in the fact
that mutations in the gene encoding Fas underlie most cases
of autoimmune lymphoproliferative syndrome (ALPS), an auto-
immune disease in children characterized bymassive lymphade-
nopathy, peripheral accumulation of doubly negative T cells, and
autoantibody production leading to hepatosplenomegaly, he-
molytic anemia, and thrombocytopenia (Straus et al., 1999).
Receptor aggregation in response to FasL binding initiates the
formation of the DISC, where the adaptor molecule Fas-associ-
ated death domain (FADD) serves as platform for recruitment
and activation of caspases-8 and -10 (Figure 2).
On the other hand, the intrinsic pathway is initiated when
apoptogenic proteins such as cytochrome c, SMAC/Diablo,
and HtrA2/Omi are released from the mitochondrial intermem-
brane space into the cytosol in response to a variety of insults,
including chemotherapeutic drugs, UV irradiation, and microbial
infection (Saelens et al., 2004). Released cytochrome c associ-
ates with the adaptor protein Apoptosis protease activating
factor-1 (Apaf-1) to form the apoptosome complex (Cain et al.,
2002). This protein complex of over 700 kDa mediates activation
of caspase-9 (Figure 2). Once activated, the respective initiator
caspases proteolytically activate ‘‘executioner caspases’’ (i.e.,
caspases-3, -6, and -7) by liberating them of their short inhibitory
prodomain. To achieve full activity, processed executioner
caspases need to be released from their endogenous inhibitor,
X-linked inhibitor of apoptosis (XIAP). This task is performed by
mitochondrial death proteins such as HtrA2/Omi and SMAC/Diablo, which possess an N-terminal IAP-binding motif (IBM) to
sequester XIAP (Saelens et al., 2004). Mature caspases-3, -6,
and -7 then cleave a large set of substrates, ultimately resulting
in the characteristic morphological and biochemical hallmarks of
apoptosis (Fischer et al., 2003; Taylor et al., 2008; Timmer and
Salvesen, 2007). For example, caspases-3 and -7 inactivate
the DNA repair enzyme poly-ADP ribose polymerase-1 (PARP-1)
and process the inhibitor of caspase-activated DNase (ICAD) to
allow oligonucleosomal DNA fragmentation by the endonu-
clease CAD (Fischer et al., 2003).
Regulation of Apoptosis during Infection
Apoptosis is not only essential for homeostasis of the immune
system, but constitutes a major factor determining clinical
progression and disease severity in host-pathogen interactions.
Indeed, apoptotic clearance of infected host cells can inhibit
microbial replication and dissemination. For example, induction
of the intrinsic apoptotic pathway in dendritic cells was recently
shown to restrict replication of the facultative intracellular path-
ogen Legionella pneumophila (Nogueira et al., 2009). Defective
or delayed induction of apoptosis can amplify disease pathogen-
esis and trigger significant tissue damage. This is illustrated by
the observation that induction of pneumococcal-associated
apoptosis through the intrinsic pathway was blocked in macro-
phages overexpressing the antiapoptotic Bcl-2 family member
Mcl-1 and prevented Mcl-1 transgenic mice from clearing pneu-
mococci from the lung efficiently (Marriott et al., 2005). The
extrinsic apoptosis pathway also contributes to resistance
against infection, because deletion of the genes encoding Fas
or FasL prevented apoptosis of lung epithelial cells following
Pseudomonas aeruginosa infection and was associated with a
dramatically increased susceptibility to sepsis-associated
lethality (Grassme´ et al., 2000). Similarly, FasL-deficient mice
were hyper-susceptible toHelicobacter pylori infection, because
their gastric epithelial cells failed to undergo apoptosis (Jones
et al., 2002). In addition to controlling microbial proliferation,
host induction of apoptosis is the preferredmechanism for termi-
nating the immune response following control of infectionCell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc. 45
Figure 2. Overview of the Extrinsic and Intrinsic Apoptotic Pathways
Death receptor ligation allows assembly of the death-inducing signaling complex (DISC), in which the caspases-8 and -10 undergo proximity-induced autoacti-
vation. Caspase-8-mediated cleavage of Bid can amplify an apoptotic signal from the extrinsic pathway by engaging the intrinsic pathway. The latter apoptotic
pathway is triggered by genotoxic stress and other stimuli that converge into activation of Bax and Bak. These proapoptotic Bcl-2 members induce release of
proapoptogenic factors such as cytochrome c, HtrA2/Omi, and SMAC/Diablo from the mitochondrial intermembrane space. Cytosolic cytochrome c associates
with Apaf-1 to assemble the apoptosome complex and activate caspase-9. Activated initiator caspases directly process the executioner caspases-3 and -7. The
latter cleave a set of cellular substrates and induce apoptosis once their inhibition by XIAP is lifted by HtrA2/Omi and SMAC/Diablo.
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mation—is limited with this mode of cell death (Haslett, 1999;
Kanaly et al., 1999).
However, induction of apoptosis is not always protective to
the host because viruses and bacteria can hijack the host’s
apoptotic machinery to eliminate the cells required for mounting
a protective immune response. To this end, many pathogens,
such as Staphylococcus aureus and Listeria monocytogenes,
produce toxins and other virulence factors that are capable of
directly activating the host’s apoptotic machinery (Weinrauch
and Zychlinsky, 1999). Alternatively, pathogens such as Yersinia
enterocolitica and Salmonella typhimurium may induce apo-
ptosis by interfering with essential host survival pathways such
as the NF-kB and MAP kinase signaling cascades (Collier-
Hyams et al., 2002; Monack et al., 1997; Orth et al., 1999). Under
these conditions, disease pathogenesis is amplified and
associated with significant tissue damage. A well-known46 Cell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc.example is that of the rapid depletion of lymphocytes in patients
infected with the human immunodeficiency virus (HIV) (Badley
et al., 2000; Selliah and Finkel, 2001). Similarly, the apoptotic
destruction of circulating lymphocytes in septic shock patients
leads to a profound and persistent lymphopenia that is associ-
ated with poor clinical outcome (Hotchkiss et al., 2005; Le Tulzo
et al., 2002). Indeed, preventing lymphocyte apoptosis with
chemical caspase inhibitors (Hotchkiss et al., 2000), in caspase-
7-deficient mice (Lamkanfi et al., 2009) or in Bcl-2-transgenic
mice (Hotchkiss et al., 1999), improved survival in the experi-
mental cecal ligation and puncture- and lipopolysaccharide
(LPS)-induced shock models.
Viruses and obligate and facultative intracellular bacterial
pathogens may also benefit from preventing apoptosis to facili-
tate intracellular replication and survival. This is reflected by the
number of virus-encoded proteins that interfere with caspase
activation or inhibit caspase activity. For example, the human
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human poxvirus molluscum contagiosum virus encode
members of the viral FLICE-inhibitory protein (v-FLIP) family
(Bertin et al., 1997; Hu et al., 1997; Thome et al., 1997). These
dominant-negative molecules prevent death receptor-mediated
apoptosis by competing with caspase-8 and -10 for recruitment
in the DISC (Shisler and Moss, 2001; Thurau et al., 2006). Cas-
pase-8 is also targeted by the cowpox virus pseudosubstrate
inhibitor cytokine response modifier A (CrmA) and its homologs
in other orthopoxviruses, including vaccinia, ectromelia, and
rabbitpox virus (Best, 2008; Dobbelstein and Shenk, 1996;
Macen et al., 1996; Turner et al., 2000). These serpins are
designed to remain firmly attached (Ki = 0.34 nM) to the active
site cysteine after being processed by caspase-8, thus blocking
enzymatic activity (Best, 2008). Apart from caspase-8, CrmA is
a highly effective inhibitor of caspase-1 (Ki = 0.01 nM), suggest-
ing that it may also have evolved to interfere with pyroptosis (see
further). The baculovirus-encoded homologs of human XIAP
represent another example of how viruses evade host cell
apoptosis (Birnbaum et al., 1994; Crook et al., 1993; Deveraux
and Reed, 1999). These viruses also encode p35, a highly effec-
tive pan-caspase inhibitor that inhibits caspases with Ki values
ranging between 0.1 and 9 nM (Zhou et al., 1998). Notably, unlike
the viral v-FLIP, CrmA, and IAP inhibitors, baculoviral p35 does
not seem to have an ortholog encoded in the human genome.
Not only viruses but also bacterial pathogens have evolved
strategies to evade apoptosis of infected host cells to their
advantage. For instance, the obligate intracellular pathogen
Rickettsia rickettsii stimulates NF-kB signaling in infected
vascular endothelial cells in order to prevent host cell death
and to continue replicating unabated (Clifton et al., 1998). Other
obligate intracellular pathogens, including Chlamydiae and
Coxiella burnetii, also protect infected cells from apoptosis
during the early invasive stages of infection, presumably by
blocking cytochrome c release from mitochondria (Fan et al.,
1998; Lu¨hrmann and Roy, 2007). Thus, the induction or inhibition
of host cell apoptosis is dependent on a delicate balance of pro-
and antiapoptotic strategies during host-pathogen interactions.
Necrosis
Morphology and Signaling Pathways
The term ‘‘necrosis’’ stems from theGreekword ‘‘nekros,’’ which
is translated as ‘‘dead body.’’ Necrosis has traditionally been
used by pathologists to refer to localized areas of dead tissue
without referring to a particular mechanism by which cell death
occurred. However, the term is also popular in the research
community as a description of a caspase-independent cell death
mode that can be observed under conditions of ischemia,
hypoxia, neoplasia, microbial infection, inflammation, and expo-
sure to toxins. Notably, many morphological features of necrotic
cells are opposite of those observed during apoptosis (Berghe
et al., 2010). For instance, apoptotic cells shrink, whereas the
cell volume of necrotic cells increases (Figure 1). Unlike the
structured oligonucleosomal DNA fragmentation observed
during apoptosis, necrosis features a more disorganized, albeit
extensive, hydrolysis of chromatin and DNA. Finally, whereas
apoptotic cells form intact, membrane-enclosed apoptotic
bodies, plasma membrane integrity is lost early during necrosis
(Figure 1). Cell lysis inevitably leads to spilling of intracellularcontents into the extracellular space. Consequently, necrosis
is considered an inherently proinflammatory and pathological
cell death mode that results in extensive tissue damage.
Necrotic cells were hypothesized to trigger inflammation through
the release of so-called ‘‘endogenous danger signals’’ or
‘‘danger-associated molecular patterns’’ (Matzinger, 1994; Shi
et al., 2000). Subsequent studies identified uric acid and the
DNA-binding protein high mobility group box 1 (HMGB1) as
critical danger signals contributing to necrosis-associated
inflammation (Scaffidi et al., 2002; Shi et al., 2003). This is illus-
trated by the observation that elimination of uric acid in vivo pre-
vented adjuvant activity from necrotic cells (Shi et al., 2003).
Similarly, necrotic cell debris from HMGB1-deficient cells was
significantly impaired in inducing proinflammatory cytokines
(Rovere-Querini et al., 2004; Scaffidi et al., 2002). In contrast,
apoptotic cells oxidize HMGB1 as a safeguard against acci-
dental induction of inflammation following engulfment of
apoptotic bodies by professional antigen-presenting cells
(Kazama et al., 2008).
Necrosis has long been regarded as a uniquely accidental cell
death mode that does not involve cellular signaling. However,
accumulating evidence indicates a programmed basis for
necrosis (Figure 3). For example, when death receptor ligation
fails to activate caspases to induce apoptosis, DISC assembly
and intracellular signalingmay result in necrotic cell death (Pobe-
zinskaya et al., 2008; Vandenabeele et al., 2006). The serine/
threonine kinases receptor interacting protein (RIP)1 and RIP3
have emerged as key regulators of necrotic signaling (Chan
et al., 2003; Cho et al., 2009; Degterev et al., 2008; He et al.,
2009; Holler et al., 2000; Zhang et al., 2009). Although dispens-
able for NF-kB activation, RIP1 kinase activity is essential for
necrosis to occur following death receptor engagement (Chan
et al., 2003; Holler et al., 2000). This interesting observation is
further corroborated by the fact that RIP1-specific inhibitors
protected against necrosis in an in vivo brain ischemia model
(Degterev et al., 2008). RIP3 kinase activity also appears essen-
tial for necrotic signaling through mechanisms unrelated to
NF-kB signaling (Cho et al., 2009; He et al., 2009). Indeed,
RIP3-deficient cells are resistant to necrosis (Cho et al., 2009;
He et al., 2009; Zhang et al., 2009), whereas NF-kB activation
proceeds unabated in these cells (Newton et al., 2004). Instead,
necrotic signaling was shown to involve the physical association
of RIP1 and RIP3, and reciprocal phosphorylation of the two
kinases has been implicated in stabilizing this interaction (Cho
et al., 2009; He et al., 2009). Although the mechanism is incom-
pletely resolved, the RIP1/RIP3 signaling cascade is believed to
result in the activation of calpains, calcium-dependent nonlyso-
somal cysteine proteases, lysosomal destabilization, and
increased ROS production (Vanlangenakker et al., 2008). In
this regard, it is interesting to note that RIP1-deficient cells
were shown to be defective in ROS production during
TNF-induced necrosis (Lin et al., 2004). Moreover, the identifica-
tion of the Caenorhabditis elegans serpin SRP-6 as an important
regulator of necrosis is in agreement with a crucial role for cal-
pains and lysosomal cysteine peptidases in inducing necrosis
(Luke et al., 2007). However, additional work is required to
determine the substrates of RIP1 and RIP3 that are responsible
for inducing necrosis and for further delineating the necrotic
signaling cascades.Cell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc. 47
Figure 3. RIP1/RIP3 Signaling Induces Necrosis
When death receptor ligation fails to induce caspase activation, the protein kinases RIP1 and RIP3 are recruited to the FADD-containing complex II. Activation of
yet unidentified kinase substrates is thought to induce necrosis through increased ROS production, calpain activation, lysosomal destabilization, and cathepsin
release.
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Reports conclusively demonstrating induction of programmed
necrosis during microbial infection are still limited because the
necrotic signaling pathways are only now beginning to emerge
and the tools for characterizing and interfering with necrotic
cell death are currently being developed. However, the recently
generated RIP1-specific small molecule inhibitors (Degterev
et al., 2008) and the availability of RIP1 (Kelliher et al., 1998)
and RIP3 knockout mice (Newton et al., 2004) will undoubtedly
prove invaluable in determining the role of necrotic cell death
during microbial infection. In this regard, viral and bacterial path-
ogens that interfere with caspase activation and apoptosis
induction (see above) are likely suspects for inducing necrotic
cell death in vivo.
Indeed, a vaccinia virus strain expressing the CrmA homolog
B13R/Spi2 was recently demonstrated to induce necrosis of
adipocytes and hepatocytes in wild-type mice, but virus-
induced tissue necrosis was markedly attenuated in RIP3
knockout mice (Cho et al., 2009). This resulted in significantly
reduced inflammatory responses and a severely impaired
restriction of viral titers in RIP3 knockout mice. As a conse-
quence, the latter succumbed by day 8, whereas the majority
of wild-type mice survived the infection (Cho et al., 2009). During
murine cytomegalovirus infection, RIP3-induced necrosis is sup-
pressed by the virus-encoded inhibitor of RIP activation, vIRA
(Upton et al., 2010). The importance of necrosis as a central48 Cell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc.mechanism of host defense against viral infections is illustrated
by the observation that vIRA mutant virus attenuation in wild-
type mice is normalized in RIP3 knockout mice (Upton et al.,
2010). Necrotic cell death was also shown in murine myoblast
cells exposed to a-toxin of the bacterial pathogen Clostridium
septicum, the causative agent of clostridial myonecrosis (Ken-
nedy et al., 2009). The toxin formed Ca2+-permeable pores in
the plasma membrane, leading to activation of calpains and
cathepsins in intoxicated cells. Moreover, mitochondrial-derived
ROS production was increased and HMGB1 was released into
the extracellular space (Kennedy et al., 2009). Thus, cellular
intoxication with pore-forming toxins may represent an impor-
tant mechanism by which pathogenic bacteria induce necrotic
cell death.
The relatively few reports investigating the in vivo conse-
quences of inducing necrosis (Cho et al., 2009; Upton et al.,
2010) suggest that it may contribute to the host’s capability to
limit and clear the infection by removing intracellular replication
niches and by enhancing the host’s defensive responses
through the release of proinflammatory cytokines and endoge-
nous danger signals.
Pyroptosis
Morphology and Signaling Pathways
Unlike the apoptotic initiator and executioner caspases (see
above), the founding father of mammalian caspases—i.e.,
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apoptosis (Li et al., 1995). Instead, caspase-1 activation in
macrophages and dendritic cells drives the proteolytic matura-
tion and secretion of the proinflammatory cytokines interleukin
(IL)-1b and IL-18 (Lamkanfi and Dixit, 2009b). Caspase-1 itself
undergoes proximity-induced autoactivation in large cytosolic
protein complexes termed ‘‘inflammasomes’’ (Lamkanfi and
Dixit, 2009b). Most inflammasomes contain a member of the
NOD-like receptor (NLR) family (Kanneganti et al., 2007). NLRs
are thought to function as sensors that detect conserved micro-
bial components in intracellular compartments, similar to the
role of mammalian Toll-like receptors (TLRs) at the cell surface
and within endosomes (Kawai and Akira, 2006). They share
a domain organization that usually includes: (1) an amino-
terminal protein-protein interaction domain such as a CARD or
pyrin domain, (2) an intermediary NACHT domain that is
required for nucleotide binding and self-oligomerization, and
(3) a variable number of carboxy-terminal leucine rich repeat
(LRR) motifs believed to be involved in sensing pathogen mole-
cules. In general, the pathogen-associated molecular patterns
(PAMPs) recognized by NLRs and TLRs are vital for microbial
survival, representing either nucleic acid structures unique to
microbes or cell wall components alien to mammalian cells.
Distinct inflammasomes are assembled, depending on the
infectious agent. Genetic studies in mice indicate that at least
four inflammasomes are formed in vivo (Figure 4): the Ipaf
inflammasome (Franchi et al., 2006; Mariathasan et al., 2004;
Miao et al., 2006), the Nlrp1b inflammasome (Boyden and Die-
trich, 2006), the Nlrp3 inflammasome (Kanneganti et al., 2006;
Mariathasan et al., 2006; Sutterwala et al., 2006), and a fourth
inflammasome that is assembled upon infection with DNA
viruses, Francisella tularensis, or Listeria monocytogenes and
contains the cytosolic double-stranded DNA sensor Absent In
Melanoma 2 (AIM2) (Fernandes-Alnemri et al., 2010; Jones
et al., 2010; Rathinam et al., 2010; Sauer et al., 2010). The bipar-
tite adaptor protein ASC bridges the interaction with caspase-1
in the AIM2 and Nlrp3 inflammasomes (Bu¨rckstu¨mmer et al.,
2009; Fernandes-Alnemri et al., 2009; Hornung et al., 2009).
Unlike AIM2 and Nlrp3, the NLR protein Ipaf can interact directly
with caspase-1 when overexpressed (Poyet et al., 2001).
However, participation of ASC in the activation of the endoge-
nous Ipaf inflammasome cannot be completely discarded,
because caspase-1 activation and the production of IL-1b and
IL-18 are dramatically impaired in ASC-deficient macrophages
that are infected with pathogens activating Ipaf in wild-type cells
such as Salmonella typhimurium and Pseudomonas aeruginosa
(Mariathasan et al., 2004; Sutterwala et al., 2007). The NLR
member Naip5/Birc1e has also been implicated in activation
of the Ipaf inflammasome because Naip5/Birc1e-deficient mac-
rophages failed to activate caspase-1 when infected with
Legionella pneumophila, another instance where the Ipaf inflam-
masome is assembled (Lightfield et al., 2008). Rather than the
CARD and pyrin domains found in most NLRs, Naip5/Birc1e
carries amino-terminal baculovirus inhibitor repeats (BIR) motifs
(Kanneganti et al., 2007). However, the molecular mechanism by
which Naip5/Birc1e mediates activation of the Ipaf inflamma-
some remains unclear.
In addition to processing proIL-1b and proIL-18, inflamma-
some-activated caspase-1 induces a specialized form of pro-grammed cell death in myeloid cells (Chen et al., 1996; Fink
and Cookson, 2006; Hersh et al., 1999; Lamkanfi et al., 2008;
Mariathasan et al., 2004; Monack et al., 1996). ‘‘Pyroptosis’’ is
the term usually adopted to describe caspase-1-dependent
cell death. This cell death mode shares features with both
apoptosis and necrosis (Figure 1). Pores of 1–2 nm appear in
the plasma membrane of pyroptotic macrophages at early time
points (Fink and Cookson, 2006). As during necrosis, this results
in cytoplasmic swelling, osmotic lysis, and release of the intra-
cellular content into the extracellular milieu. The fact that cas-
pase-1 activation is linked with the production of mature IL-1b
and IL-18 renders pyroptosis an inherently proinflammatory
cell death mode. Unlike necrosis but similar to apoptosis,
nuclear condensation and oligonucleosomal DNA fragmentation
are observed during pyroptosis (Fink and Cookson, 2006; Lam-
kanfi et al., 2008; Monack et al., 1996). Although caspase-1
activity is required (Lamkanfi et al., 2008; Monack et al., 1996),
pyroptosis occurs independently of IL-1b and IL-18 (Monack
et al., 2001). Moreover, maturation of executioner caspases-3
and -7 is observed during pyroptosis (Akhter et al., 2009; Lam-
kanfi et al., 2008), but DNA fragmentation and plasmamembrane
permeabilization proceed unabated in macrophages lacking
either of the executioner caspases (Hilbi et al., 1998; Lamkanfi
et al., 2008). This is not completely unexpected, as caspase-3
and -7 are partially redundant and deficiency of both is required
for protection against apoptosis (Lakhani et al., 2006). However,
we found that Salmonella typhimurium-induced pyroptosis was
not affected in bone marrow-derived macrophages (BMDMs)
lacking both caspases-3 and -7 (M.L. and V.M.D., unpublished
data). Similarly, BMDMs from RIP3-deficient mice were not
protected from Salmonella-induced pyroptosis (M.L. and
V.M.D., unpublished data). Thus, although pyroptosis shares
features with apoptosis and necrosis, these findings demon-
strate that the signaling pathways involved are distinct, and the
molecular mechanism by which caspase-1 induces pyroptosis
remains to be uncovered.
Regulation of Pyroptosis during Infection
Shigella flexneri, the etiological agent of bacillary dysentery, was
the first pathogen reported to induce pyroptosis in infected
macrophages (Chen et al., 1996; Hilbi et al., 1998). Subsequent
studies demonstrated pyroptotic death of macrophages and
dendritic cells infected with Salmonella typhimurium, Pseudo-
monas aeruginosa, and Legionella pneumophila (Lamkanfi and
Dixit, 2009b; Monack et al., 2001; van der Velden et al., 2003).
These pathogens all induce caspase-1 activation through the
Ipaf inflammasome (Lamkanfi and Dixit, 2009b). With the notable
exception of Shigella, this happens following delivery of bacterial
flagellin into the macrophage cytosol. Because Shigella lacks
flagellin, it remains to be determined how this pathogen induces
activation of the Ipaf inflammasome. Unlike the former patho-
gens, the causative agent of tularemia, Francisella tularensis,
induces caspase-1 activation through the AIM2 inflammasome
(Fernandes-Alnemri et al., 2010; Jones et al., 2010; Rathinam
et al., 2010). Vacuolar escape and type I interferon signaling
are required for AIM2 induction and Francisella-induced pyrop-
tosis (Henry et al., 2007; Jones et al., 2010; Mariathasan et al.,
2005). Caspase-1 activation plays a vital role in the immune
response to this pathogen, because caspase-1-deficient mice
were shown to be hypersusceptible to Francisella infectionCell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc. 49
Figure 4. Caspase-1 Activation in Inflammasomes Induces Pyroptosis
Pathogen invasion of macrophages and dendritic cells induces assembly of inflammasome complexes in which caspase-1 is activated. Caspase-1 subsequently
processes the proinflammatory cytokines IL-1b and IL-18 into their biologically active forms, activates caspase-7, and cleaves yet unidentified substrates that are
responsible for early membrane permeabilization and oligonucleosomal DNA fragmentation during pyroptosis.
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recently reported to occur in macrophages infected with Listeria
monocytogenes (Sauer et al., 2010). The Nlrp3 inflammasome is
responsible for inducing pyroptosis in response to Staphylo-
coccus aureus infection following the hemolysin-mediated
delivery of a yet unidentified bacterial compound into themacro-
phage cytosol (Mariathasan et al., 2006; Mun˜oz-Planillo et al.,
2009). Finally, pyroptosis is observed upon Bacillus anthracis
infection when the anthrax metalloprotease lethal factor (LF)
gains access to the cytosol of susceptible macrophages (Terra
et al., 2010). Indeed, activation of caspase-1 by the Nlrp1b
inflammasome was identified as the key determinant of LF50 Cell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc.susceptibility (Boyden and Dietrich, 2006). LF-induced pyropto-
sis confers resistance to infection with Bacillus anthracis spores
in vivo (Terra et al., 2010). It is thus not surprising that besides the
caspase-1/-8 inhibitor CrmA (see above), poxviruses have also
evolved decoy molecules that interfere with inflammasome
assembly and pyroptosis induction. In this regard, the myxoma
virus M013 and Shope Fibroma virus vPOP pyrin-only proteins
attenuate inflammasome activation (Johnston et al., 2005),
similar to the role of the CARD-only and pyrin-only proteins en-
coded in the human genome (Stehlik and Dorfleutner, 2007).
The existence of virally encoded decoy inhibitors suggests a vital
role for inflammasome activation in the immune response
Cell Host & Microbe
Reviewagainst pathogens. The beneficial role of phagocyte pyroptosis
is best illustrated by the protection it provides against infection
with Bacillus anthracis spores (Terra et al., 2010). As with
necrosis, the destruction of intracellular replication niches and
the release of inflammatory cytokines and endogenous alarmins
such as HMGB1 may represent key mechanisms by which
pyroptosis may contribute to the host’s anti-infectious
responses.
Conclusions
Our understanding of the role of programmed cell death inmicro-
bial infections has markedly increased in recent years. We have
learned that host-pathogen interactions in inducing programmed
host cell death are highly complex and involve a delicate balance
between the host’s defensive responses and the pathogen’s
virulence mechanisms. Apoptosis, necrosis, and pyroptosis
represent the three major programmed cell death modes during
infection, and the choice of death mode depends on a variety
of factors, including the nature of the pathogen, pathogen load,
and the site of infection. Indeed, various host cell types are likely
to react differently to an infectious agent. For example, Shigella
flexneri inhibits apoptosis in epithelial cells (Clark and Maurelli,
2007) but triggers apoptotic and pyroptotic cell death of infected
macrophages (Hilbi et al., 1998; Suzuki et al., 2005). A major
difference in the biological outcome of inducing apoptosis,
necrosis, or pyroptosis is the ensuing inflammatory response.
Apoptosis is generally immunologically silent (reviewed in Savill
et al., 2002), while necrosis and pyroptosis are accompanied by
secretion of proinflammatory cytokines and the extracellular
release of the cytosolic content (Berghe et al., 2010; Lamkanfi
and Dixit, 2009a). Undoubtedly, further insight into the complex
relationship between hosts and pathogens will be gained
by further elucidating the molecular mechanisms underlying
necrosis and pyroptosis, as well as by characterizing newmech-
anismsbywhichmicrobes induce and evade apoptotic, necrotic,
and pyroptotic cell death in their hosts.
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